Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity
Year: 2013
Type: article
Abstract: The role of macrophage lipoprotein lipase (LpL) in the development of atherosclerosis and adiposity was examined in macrophage LpL knockout (MLpLKO) mice. MLpLKO mice were generated using cre-loxP gene targeting. Loss of LpL in macrophages did not alter plasma LpL activity or lipoprotein levels. Incubation of apolipoprotein E (ApoE)-deficient β-VLDL with peritoneal macrophages from ApoE knockout mice lacking macrophage LpL (MLpLKO/ApoEKO) led to less cholesteryl ester formation than that found with ApoEKO macrophages. MLpLKO/ApoEKO macrophages had reduced intracellular triglyceride levels, with decreased CD36 and carnitine palmitoyltransferase-1 mRNA levels compared with ApoEKO macrophages, when incubated with VLDL. Although both MLpLKO/ApoEKO and ApoEKO mice developed comparable hypercholesterolemia in response to feeding with a Western-type diet for 12 weeks, atherosclerosis was less in MLpLKO/ApoEKO mice. Epididymal fat mass and gene expression levels associated with inflammation did not differ between the two groups. In conclusion, macrophage LpL plays an important role in the development of atherosclerosis but not adiposity.
Source: Journal of Lipid Research
DOI: 10.1194/jlr.m035568
Institutions: Jichi Medical University, Columbia University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
Awards: Pathways of Tissue Lipid Uptake, Study on the endoplasmic stress induced by oxsterol ester and its implication to diseases, G3992498628, EXTRACELLULAR REGULATION OF LIPOPROTEIN LIPASE ACTIVITY, Development of a novel therapy for atherosclerosis based on alleviation of lipotoxicity of macrophages, Genetic analysis of molecular mechanisms of foam cell formation in atherosclerosis, G9000247361, New York Obesity Research Center
OpenAlex ID: W2142416256
